Apellis Pharmaceuticals, Inc. Reports annual revenue of $396.6 million
Company Records $528.6 million loss
By USInMinutes
Published - Mar 05, 2024, 09:07 AM ET
Last Updated - Mar 05, 2024, 09:07 AM EST
Apellis Pharmaceuticals, Inc. [APLS] has reported $396.6 million in revenue for year ended Dec 31, 2023.
Also Read:
